Literature DB >> 24898312

The effect of selective serotonin reuptake inhibitor (SSRI) on pain-related behavior in a rat model of neuropathic pain.

Hiroharu Saito1, Jun Wakai, Miho Sekiguchi, Shinichi Kikuchi, Shinichi Konno.   

Abstract

INTRODUCTION: Some antidepressants are effective for treating neuropathic pain independent of any effect on depression. Selective serotonin reuptake inhibitors (SSRIs) are one of the potential agents to treat neuropathic pain. The aims of this study were to compare the effects of SSRI and non-steroidal anti-inflammatory drugs (NSAIDs) on pain-related behavior and expression of cytokines in a rat model of neuropathic pain.
MATERIALS AND METHODS: Spinal surgery was performed to apply nucleus pulposus (NP) to the dorsal root ganglion (DRG). NP animals were treated with saline (NP + S), meloxicam (NP + M), or low-dose or high-dose paroxetine (NP + PL and NP + PH), respectively. Behavioral testing was performed to investigate the mechanical withdrawal thresholds. The numbers of TNF-immunoreactive (IR) neurons in the DRG and of Iba1-IR microglia in the spinal cord (SC) were evaluated using immunohistochemistry. Expression of TNF in the DRG was examined using Western blots.
RESULTS: The thresholds on days 14, 21, and 28 were higher in the drug-treated animals than in the NP + S group (p < 0.05). The number of TNF-IR neurons in DRGs from the NP + M group increased on day 2 and decreased on day 7, and TNF expression in DRGs was significantly higher in the NP + S group than in the NP + M group on days 7, 14. The number of Iba1-IR microglia in the SC was significantly higher in the NP + S group than in the NP + M, NP + PL, and NP + PH groups on days 7 and 14.
CONCLUSION: An antidepressant might be a potential agent to treat lumbar disc herniation as well as NSAIDs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24898312     DOI: 10.1007/s00586-014-3392-x

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  45 in total

1.  Analgesic effects of prostaglandin E2 receptor subtype EP1 receptor antagonist: experimental study of application of nucleus pulposus.

Authors:  Miho Sekiguchi; Kenichi Otoshi; Shin-ichi Kikuchi; Shin-ichi Konno
Journal:  Spine (Phila Pa 1976)       Date:  2011-10-15       Impact factor: 3.468

2.  Presynaptic P2X receptors facilitate inhibitory GABAergic transmission between cultured rat spinal cord dorsal horn neurons.

Authors:  S Hugel; R Schlichter
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

3.  ATP P2x receptors and sensory synaptic transmission between primary afferent fibers and spinal dorsal horn neurons in rats.

Authors:  P Li; A A Calejesan; M Zhuo
Journal:  J Neurophysiol       Date:  1998-12       Impact factor: 2.714

Review 4.  Functional plasticity of microglia: a review.

Authors:  W J Streit; M B Graeber; G W Kreutzberg
Journal:  Glia       Date:  1988       Impact factor: 7.452

5.  Pathomechanism of pain-related behavior produced by allografts of intervertebral disc in the rat.

Authors:  M Kawakami; T Tamaki; J N Weinstein; H Hashizume; H Nishi; S T Meller
Journal:  Spine (Phila Pa 1976)       Date:  1996-09-15       Impact factor: 3.468

Review 6.  The role of microglia and macrophages in the pathophysiology of the CNS.

Authors:  G Stoll; S Jander
Journal:  Prog Neurobiol       Date:  1999-06       Impact factor: 11.685

7.  Increased expression of vascular endothelial growth factor protein in dorsal root ganglion exposed to nucleus pulposus on the nerve root in rats.

Authors:  Shinji Miyoshi; Miho Sekiguchi; Shin-ichi Konno; Shin-ichi Kikuchi; Fuminori Kanaya
Journal:  Spine (Phila Pa 1976)       Date:  2011-01-01       Impact factor: 3.468

Review 8.  Crossing the pain barrier: P2 receptors as targets for novel analgesics.

Authors:  C Kennedy; T S Assis; A J Currie; E G Rowan
Journal:  J Physiol       Date:  2003-09-26       Impact factor: 5.182

9.  Tumor necrosis factor alpha and nucleus-pulposus-induced nerve root injury.

Authors:  K Olmarker; K Larsson
Journal:  Spine (Phila Pa 1976)       Date:  1998-12-01       Impact factor: 3.468

10.  Antinociceptive effect of intrathecally administered P2-purinoceptor antagonists in rats.

Authors:  B Driessen; W Reimann; N Selve; E Friderichs; R Bültmann
Journal:  Brain Res       Date:  1994-12-15       Impact factor: 3.252

View more
  6 in total

1.  Experimental Disc Herniation in the Rat Causes Downregulation of Serotonin Receptor 2c in a TNF-dependent Manner.

Authors:  Daniel Jonsson; Oscar Finskas; Yuki Fujioka; Anders Ståhlberg; Kjell Olmarker
Journal:  Clin Orthop Relat Res       Date:  2015-06       Impact factor: 4.176

2.  The effect of serotonin-noradrenaline reuptake inhibitor duloxetine on the intervertebral disk-related radiculopathy in rats.

Authors:  Junichi Handa; Miho Sekiguchi; Olga Krupkova; Shin-Ichi Konno
Journal:  Eur Spine J       Date:  2015-09-22       Impact factor: 3.134

3.  Acetaminophen combined with tramadol is more effective than acetaminophen or tramadol to reduce neuropathic root pain: an experimental study with application of nucleus pulposus in a rat model.

Authors:  Ryohei Sato; Miho Sekiguchi; Shin-Ichi Konno
Journal:  Eur Spine J       Date:  2019-10-21       Impact factor: 3.134

4.  The anti-inflammatory effects of venlafaxine in the rat model of carrageenan-induced paw edema.

Authors:  Valiollah Hajhashemi; Mohsen Minaiyan; Hamid Reza Banafshe; Azam Mesdaghinia; Alireza Abed
Journal:  Iran J Basic Med Sci       Date:  2015-07       Impact factor: 2.699

5.  Association of Serum Serotonin and Pain in Patients with Chronic Low Back Pain before and after Spinal Surgery.

Authors:  Afshin Farhanchi; Behrouz Karkhanei; Negar Amani; Mashhood Aghajanloo; Elham Khanlarzadeh; Zahra Emami
Journal:  Pain Res Treat       Date:  2018-09-20

6.  Benefit of small dose antidepressants for functional dyspepsia: Experience from a tertiary center in eastern China.

Authors:  Liang Luo; Lijun Du; Jinhua Shen; Mengsha Cen; Ning Dai
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.